Article,

Examining the In Vitro Efficacy of the IAP Antagonist Birinapant as a Single Agent or in Combination With Dacarbazine to Induce Melanoma Cell Death

, , , , , and .
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 25 (9): 1489--1494 (November 2017)
DOI: 10.3727/096504017x14897145996933

Meta data

Tags

Users

  • @cristiano
  • @fabian

Comments and Reviews